Raman-Tangella Vidya

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$1.54M

Insider Activity of Raman-Tangella Vidya

According to the SEC Form 4 filings, Raman-Tangella Vidya, being in a position of

  1. CHIEF MEDICAL OFFICER at Teladoc Health, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 56663 shares for $988,085,
    over all time since 2023-05-02, has bought 0 shares, and sold 77250 shares for $1.54M.

The largest sale of all time was on 2023-12-26 and amounted to 27310 shares of Teladoc Health, Inc. for $600,820.

Biography of Raman-Tangella Vidya

No biography is available at this moment.

2024-09-04SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
468
0.0003%
$7.26$3,398+16.6%
2024-09-03SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
1,114
0.0006%
$7.16$7,981+17.48%
2024-08-05SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
1,537
0.0009%
$7.33$11,266-2.11%
2024-08-02SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
3,857
0.0023%
$8.14$31,404-6.1%
2024-06-04SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
468
0.0003%
$11.04$5,167-19.69%
2024-06-03SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
1,122
0.0007%
$11.16$12,518-21.12%
2024-05-31SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
3,407
0.002%
$11.21$38,192-22.22%
2024-05-02SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
3,691
0.0021%
$12.69$46,831-28.38%
2024-03-04SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
4,599
0.0027%
$14.52$66,759-24.78%
2024-02-02SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
4,128
0.0024%
$19.18$79,167-38.35%
2023-12-26SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
27,310
0.0165%
$22.00$600,820-40.89%
2023-11-02SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
4,962
0.003%
$17.05$84,582-14.35%
2023-08-02SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
5,215
0.0033%
$27.03$140,956-33.78%
2023-05-02SaleTeladoc Health, Inc.
TDOC
CHIEF MEDICAL OFFICER
15,372
0.0097%
$26.76$411,401-21.69%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.